Major Depressive Episodes Far More Common than Previously Believed, New Study Finds
The number of adults in the United States who suffer from major depressive episodes at some point in their life is far higher than previously believed, a new study by the Yale School of Public Health finds. National survey data currently shows that approximately 17% of women and 10% of men report having a history of major depressive episodes (MDEs) in their lifetimes. But these data are subject to “recall error,” or the tendency of people to forget or misreport their health histories when taking a survey.
YSPH Statement Regarding Hydroxychloroquine
Dr. Harvey Risch is a distinguished cancer epidemiologist who has opined on the topic of hydroxychloroquine (HCQ) and COVID-19 out-patient therapy. He has written a review article in the American Journal of Epidemiology that cites evidence that he believes supports HCQ use for out-patient infection with SARS-CoV-2. Studies that indicate no effect or harmful effects, Dr. Risch believes, enrolled patients too sick to benefit from HCQ.
Diverse Scholars Institute Supports Underrepresented Faculty
For the past 10 years, Yale University’s Research Education Institute for Diverse Scholars (REIDS) has focused on enhancing the abilities of underrepresented minority faculty in navigating the structural and personal challenges experienced in their early academic careers.
New Center in Implementation Science Launched with University of Malaya
Yale University and the University of Malaya (UM) in Kuala Lumpur have been awarded a multi-million grant to establish the Malaysian Implementation Science Training (MIST) center to catalyze research and training through the Fogarty International Program at the National Institutes of Health.
What COVID-19 is Teaching Us About Humanitarian Responses: Part I
6.25.20 “COVID-19 Right Now” featuring Kaveh Khoshnood, PhD, MPH, Associate Professor of Epidemiology and Program Co-Director for the Global Ethics Program at the Yale Institute of Global Health; and James Hamblin, MD, MPH, Lecturer in Health Policy and Management
Yale School of Public Health Town Hall Focuses on Diversity, Inclusion and Social Justice
More than 120 members of the Yale School of Public Health community participated in a virtual town hall this week to discuss ideas about how the school can better address diversity, inclusion and social justice moving forward.
COVID-19 has generated renewed attention to the stark racial disparities in health that persist in the United States. The cause of these disparities is racism that manifests in individual behaviors, in laws and policies and in the current and historical structures of almost every aspect of U.S. society.
Yale and NBA Partner to Study Efficacy of New COVID-19 Test
A research team led by Yale’s Nathan Grubaugh and Anne Wyllie will begin testing select players, coaches, and staff from the NBA teams that have opted into the study, using a testing method they developed, known as SalivaDirect. The results of the study are expected by the end of July and will be shared publicly.Source: YaleNews
Racism, Homelessness, and DreamKit
In order to effectively end mass homelessness, we must first address structural racism. If we fix the homelessness crisis for Black people, we’ll fix it for everyone. Why do Black people make up only 13% of the U.S. population, but represent 40% of the homeless population? It’s because of systemic racism, discrimination and oppression. Even when controlling for poverty, Black Americans are dramatically more likely than Whites to become homeless.
A Look at Russia’s Response to the Coronavirus
6.18.20 “COVID-19 Right Now” featuring Robert Heimer, PhD, Professor of Epidemiology of Microbial Diseases; Judyth Twigg, PhD, professor of political science, Virginia Commonwealth University; and James Hamblin, MD, MPH, Lecturer, Health Policy and Management.